Rhett P. Ketterling
#164,960
Most Influential Person Now
Researcher
Rhett P. Ketterling's AcademicInfluence.com Rankings
Rhett P. Ketterlingcomputer-science Degrees
Computer Science
#9814
World Rank
#10296
Historical Rank
Computational Linguistics
#2414
World Rank
#2438
Historical Rank
Machine Learning
#4393
World Rank
#4443
Historical Rank
Artificial Intelligence
#4747
World Rank
#4810
Historical Rank
Download Badge
Computer Science
Rhett P. Ketterling's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science Stanford University
Similar Degrees You Can Earn
Why Is Rhett P. Ketterling Influential?
(Suggest an Edit or Addition)Rhett P. Ketterling's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. (2012) (1728)
- Mutations and prognosis in primary myelofibrosis (2013) (659)
- Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis. (2014) (552)
- CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy. (2003) (372)
- ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes. (2014) (363)
- Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases. (2005) (358)
- Microduplication 22q11.2, an emerging syndrome: clinical, cytogenetic, and molecular analysis of thirteen patients. (2003) (351)
- Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. (1995) (343)
- T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993). (2009) (327)
- Anthracycline dose intensification in acute myeloid leukemia. (2009) (308)
- Genetic aberrations and survival in plasma cell leukemia (2008) (295)
- FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia. (2004) (291)
- MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis. (2017) (287)
- Lenalidomide therapy in myelofibrosis with myeloid metaplasia. (2006) (256)
- ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients (2014) (231)
- Targeted deep sequencing in polycythemia vera and essential thrombocythemia. (2016) (225)
- HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trial. (2010) (222)
- Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics. (2012) (221)
- Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905. (2014) (211)
- SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value. (2012) (206)
- Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma (2006) (200)
- Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas. (2012) (200)
- Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999. (2010) (191)
- Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: A collaborative study of 1027 patients (2014) (184)
- One thousand patients with primary myelofibrosis: the mayo clinic experience. (2012) (183)
- Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma (2013) (182)
- MIPSS70+ Version 2.0: Mutation and Karyotype-Enhanced International Prognostic Scoring System for Primary Myelofibrosis. (2018) (181)
- GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis (2018) (176)
- Factor VIII gene inversions causing severe hemophilia A originate almost exclusively in male germ cells. (1994) (174)
- Clinical correlates of JAK2V617F allele burden in essential thrombocythemia (2007) (169)
- Targeted deep sequencing in primary myelofibrosis. (2016) (163)
- SRSF2 mutations in primary myelofibrosis: significant clustering with IDH mutations and independent association with inferior overall and leukemia-free survival. (2012) (160)
- Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS. (2012) (156)
- Clonally related Histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: A study of 7 cases (2011) (148)
- Chromosomal Rearrangements of 6p25.3 Define a New Subtype of Lymphomatoid Papulosis (2013) (148)
- Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: Prevalence, clinical correlates, and prognostic relevance (2013) (143)
- The prognostic advantage of calreticulin mutations in myelofibrosis might be confined to type 1 or type 1-like CALR variants. (2014) (135)
- Mutations causing hemophilia B: direct estimate of the underlying rates of spontaneous germ-line transitions, transversions, and deletions in a human gene. (1990) (134)
- Relationship of patient survival and chromosome anomalies detected in metaphase and/or interphase cells at diagnosis of myeloma. (2005) (126)
- Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic‐French Consortium Study (2014) (124)
- Mutation‐enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera (2020) (110)
- Bone marrow JAK2V617F allele burden and clinical correlates in polycythemia vera (2007) (103)
- Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups. (2016) (103)
- Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016 (2017) (101)
- Missense mutations and evolutionary conservation of amino acids: evidence that many of the amino acids in factor IX function as "spacer" elements. (1991) (97)
- CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900. (2012) (94)
- Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts (2018) (92)
- Preclinical validation of fluorescence in situ hybridization assays for clinical practice (2006) (92)
- Genetic subtyping of breast implant-associated anaplastic large cell lymphoma. (2018) (89)
- Revised cytogenetic risk stratification in primary myelofibrosis: analysis based on 1002 informative patients (2018) (89)
- Interphase fluorescence in situ hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category (2017) (88)
- Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis (2009) (87)
- Driver mutations and prognosis in primary myelofibrosis: Mayo‐Careggi MPN alliance study of 1,095 patients (2018) (85)
- Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia. (2012) (83)
- Utility of ALK-1 protein expression and ALK rearrangements in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell lesions of the urinary bladder (2007) (82)
- Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements (2016) (81)
- Germ-line origins of mutation in families with hemophilia B: the sex ratio varies with the type of mutation. (1993) (79)
- Analysis of intratumoral heterogeneity and amplification status in breast carcinomas with equivocal (2+) HER-2 immunostaining. (2005) (79)
- Targeted next-generation sequencing in blast phase myeloproliferative neoplasms. (2018) (77)
- Cytogenetic studies at diagnosis in polycythemia vera: clinical and JAK2V617F allele burden correlates (2008) (77)
- Extending Jak2V617F and MplW515 Mutation Analysis to Single Hematopoietic Colonies and B and T Lymphocytes (2007) (76)
- 3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk‐Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups (2019) (75)
- Very poor long‐term survival in past and more recent studies for relapsed AML patients: The ECOG‐ACRIN experience (2018) (71)
- Molecular Diagnosis of Ewing's Sarcoma/Primitive Neuroectodermal Tumor in Formalin-Fixed Paraffin-Embedded Tissues by RT-PCR and Fluorescence In Situ Hybridization (2005) (70)
- DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study. (2017) (68)
- Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements. (2018) (68)
- Primary myelodysplastic syndrome with normal cytogenetics: utility of 'FISH panel testing' and M-FISH. (2002) (66)
- Prognostic irrelevance of ring sideroblast percentage in World Health Organization-defined myelodysplastic syndromes without excess blasts. (2011) (66)
- Clonally Related Follicular Lymphomas and Langerhans Cell Neoplasms: Expanding the Spectrum of Transdifferentiation (2013) (66)
- Targeted next‐generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS‐R (2017) (66)
- New highly sensitive fluorescence in situ hybridization method to detect PML/RARA fusion in acute promyelocytic leukemia. (2003) (65)
- Autologous transplantation gives encouraging results for young adults with favorable-risk acute myeloid leukemia, but is not improved with gemtuzumab ozogamicin. (2011) (64)
- U2AF1 mutation types in primary myelofibrosis: phenotypic and prognostic distinctions (2018) (64)
- C-MYC alterations and association with patient outcome in early-stage HER2-positive breast cancer from the north central cancer treatment group N9831 adjuvant trastuzumab trial. (2011) (63)
- Biologic and genetic characterization of the novel amyloidogenic lambda light chain-secreting human cell lines, ALMC-1 and ALMC-2. (2008) (62)
- Mutation-Enhanced International Prognostic Scoring System (MIPSS) for Primary Myelofibrosis: An AGIMM & IWG-MRT Project (2014) (61)
- Predictors of survival in refractory anemia with ring sideroblasts and thrombocytosis (RARS‐T) and the role of next‐generation sequencing (2016) (61)
- Utility of subtelomeric fluorescent DNA probes for detection of chromosome anomalies in 425 patients (2003) (61)
- DNMT3A mutations are associated with inferior overall and leukemia‐free survival in chronic myelomonocytic leukemia (2017) (60)
- ROSETTE‐FORMING GLIONEURONAL TUMOR: REPORT OF A CHIASMAL‐OPTIC NERVE EXAMPLE IN NEUROFIBROMATOSIS TYPE 1 SPECIAL PATHOLOGY REPORT (2009) (60)
- Section E9 of the American College of Medical Genetics technical standards and guidelines: Fluorescence in situ hybridization (2011) (58)
- Abnormal FISH in patients with immunoglobulin light chain amyloidosis is a risk factor for cardiac involvement and for death (2015) (57)
- 'Idiopathic' eosinophilia with an Occult T-cell clone: prevalence and clinical course. (2007) (57)
- Pituitary blastoma (2008) (57)
- The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma. (2015) (56)
- Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma (2017) (56)
- Recurrent STAT3-JAK2 fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract. (2018) (56)
- Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapie. (2010) (55)
- Whole-exome analysis reveals novel somatic genomic alterations associated with outcome in immunochemotherapy-treated diffuse large B-cell lymphoma (2015) (55)
- The factor IX gene as a model for analysis of human germline mutations: an update. (1996) (54)
- Pediatric histiocytic sarcoma clonally related to precursor B‐cell acute lymphoblastic leukemia with homozygous deletion of CDKN2A encoding p16INK4A (2011) (54)
- Histiocytoid Sweet syndrome may indicate leukemia cutis: a novel application of fluorescence in situ hybridization. (2014) (53)
- Next‐generation sequencing in systemic mastocytosis: Derivation of a mutation‐augmented clinical prognostic model for survival (2016) (53)
- Reflex fluorescent in situ hybridization testing for unsuccessful product of conception cultures: A retrospective analysis of 5555 samples attempted by conventional cytogenetics and fluorescent in situ hybridization (2011) (52)
- Targeted next generation sequencing and identification of risk factors in World Health Organization defined atypical chronic myeloid leukemia (2017) (52)
- Establishment and characterization of a novel Waldenstrom macroglobulinemia cell line, MWCL-1. (2011) (51)
- Azacitidine with or without Entinostat for the treatment of therapy‐related myeloid neoplasm: further results of the E1905 North American Leukemia Intergroup study (2016) (51)
- Karyotype complements the International Prognostic Scoring System for primary myelofibrosis (2009) (51)
- Cytogenetic abnormalities in essential thrombocythemia: prevalence and prognostic significance (2009) (50)
- Evidence that descendants of three founders constitute about 25% of hemophilia B in the United States. (1991) (50)
- Mayo alliance prognostic system for mastocytosis: clinical and hybrid clinical-molecular models. (2018) (49)
- Reported in vivo splice‐site mutations in the factor IX gene: Severity of splicing defects and a hypothesis for predicting deleterious splice donor mutations (1999) (48)
- Therapy related‐chronic myelomonocytic leukemia (CMML): Molecular, cytogenetic, and clinical distinctions from de novo CMML (2018) (47)
- Treatment-influenced associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia. (2012) (47)
- Myeloproliferative neoplasms in the young: Mayo Clinic experience with 361 patients age 40 years or younger (2018) (46)
- Leukemic transformation among 1306 patients with primary myelofibrosis: risk factors and development of a predictive model (2019) (46)
- Mutations and prognosis in myelodysplastic syndromes: karyotype‐adjusted analysis of targeted sequencing in 300 consecutive cases and development of a genetic risk model (2018) (45)
- Novel FISH probes designed to detect IGK-MYC and IGL-MYC rearrangements in B-cell lineage malignancy identify a new breakpoint cluster region designated BVR2 (2006) (45)
- ALK-1 protein expression and ALK gene rearrangements aid in the diagnosis of inflammatory myofibroblastic tumors of the female genital tract. (2012) (45)
- Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history (2015) (45)
- Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements (2018) (44)
- Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients (2019) (43)
- The pattern of factor IX germ-line mutation in Asians is similar to that of Caucasians. (1990) (43)
- Why does the human factor IX gene have a G + C content of 40%? (1991) (43)
- The rates and patterns of deletions in the human factor IX gene. (1994) (43)
- Development of acute megakaryoblastic leukemia in Down syndrome is associated with sequential epigenetic changes. (2013) (42)
- Spectrum of autoimmune diseases and systemic inflammatory syndromes in patients with chronic myelomonocytic leukemia (2017) (41)
- Calreticulin variant stratified driver mutational status and prognosis in essential thrombocythemia (2016) (41)
- Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response (2020) (41)
- Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities. (2020) (41)
- Momelotinib therapy for myelofibrosis: a 7-year follow-up (2018) (40)
- CCND1 rearrangements and cyclin D1 overexpression in renal oncocytomas: frequency, clinicopathologic features, and utility in differentiation from chromophobe renal cell carcinoma. (2009) (40)
- Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 interpretation in breast cancer. (2010) (40)
- t(8;9)(p22;p24)/PCM1-JAK2 Activates SOCS2 and SOCS3 via STAT5 (2012) (39)
- Chromosome 8p11.2 translocations: Prevalence, FISH analysis for FGFR1 and MYST3, and clinicopathologic correlates in a consecutive cohort of 13 cases from a single institution (2010) (38)
- Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping. (2017) (38)
- Rearrangements and amplification of IER3 (IEX-1) represent a novel and recurrent molecular abnormality in myelodysplastic syndromes. (2009) (36)
- EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental (2018) (36)
- Analysis of genetic abnormalities provides insights into genetic evolution of hyperdiploid myeloma (2006) (36)
- Sex and degree of severity influence the prognostic impact of anemia in primary myelofibrosis: analysis based on 1109 consecutive patients (2018) (36)
- DUSP22 AND TP63 REARRANGEMENTS PREDICT OUTCOME OF ALK‐NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA: A DANISH COHORT STUDY (2017) (36)
- Histologic and immunohistochemical study of bone marrow monocytic nodules in 21 cases with myelodysplasia. (2003) (36)
- Recurrent MSC E116K mutations in ALK-negative anaplastic large cell lymphoma. (2019) (35)
- Integration of Mutations and Karyotype Towards a Genetics-Based Prognostic Scoring System (GPSS) for Primary Myelofibrosis (2014) (35)
- The rates of G:C-->T:A and G:C-->C:G transversions at CpG dinucleotides in the human factor IX gene. (1994) (35)
- Impact of acquired del(17p) in multiple myeloma. (2019) (35)
- Intralymphatic Cutaneous Anaplastic Large Cell Lymphoma/Lymphomatoid Papulosis: Expanding the Spectrum of CD30-positive Lymphoproliferative Disorders (2014) (34)
- Evaluation of revised IPSS cytogenetic risk stratification and prognostic impact of monosomal karyotype in 783 patients with primary myelodysplastic syndromes (2013) (34)
- Monocytosis in polycythemia vera: Clinical and molecular correlates (2016) (34)
- Prefibrotic versus overtly fibrotic primary myelofibrosis: clinical, cytogenetic, molecular and prognostic comparisons (2016) (33)
- High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcome (2014) (33)
- A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patients (2014) (32)
- Allogeneic hematopoietic stem cell transplant overcomes the adverse survival effect of very high risk and unfavorable karyotype in myelofibrosis (2018) (32)
- Splenic small B-cell lymphoma with IGH/BCL3 translocation. (2006) (31)
- Functioning Paraganglioma and Gastrointestinal Stromal Tumor of the Jejunum in Three Women: Syndrome or Coincidence (2006) (31)
- Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myeloma (2015) (30)
- Chronic lymphocytic leukemia with t(14;19)(q32;q13) is characterized by atypical morphologic and immunophenotypic features and distinctive genetic features. (2011) (30)
- Chronic lymphocytic leukemia With t(2;14)(p16;q32) involves the BCL11A and IgH genes and is associated with atypical morphologic features and unmutated IgVH genes. (2009) (30)
- An MLL-SEPT9 fusion and t(11;17)(q23;q25) associated with de novo myelodysplastic syndrome. (2007) (29)
- Germline mutations in the factor IX gene: a comparison of the pattern in Caucasians and non-Caucasians. (1993) (29)
- Chromosome 1 abnormalities in myeloid malignancies: a literature survey and karyotype–phenotype associations (2010) (29)
- Molecular Classification Improves Risk Assessment in Adult BCR-ABL1-negative B-ALL. (2021) (28)
- Polyclonal immunoglobulin free light chain levels predict survival in myeloid neoplasms. (2012) (28)
- Clinicopathologic characteristics, prognostication and treatment outcomes for myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): Mayo Clinic-Moffitt Cancer Center study of 135 consecutive patients (2019) (28)
- Image analysis of HER2 immunohistochemical staining. Reproducibility and concordance with fluorescence in situ hybridization of a laboratory-validated scoring technique. (2012) (27)
- Desmoplastic small round cell tumor of the central nervous system: report of two cases and review of the literature (2009) (27)
- Mate pair sequencing improves detection of genomic abnormalities in acute myeloid leukemia (2018) (27)
- Monocytosis is a powerful and independent predictor of inferior survival in primary myelofibrosis (2018) (27)
- Chromosome 9p24 abnormalities: prevalence, description of novel JAK2 translocations, JAK2V617F mutation analysis and clinicopathologic correlates (2010) (27)
- Prognostic significance of interphase FISH in monoclonal gammopathy of undetermined significance (2018) (26)
- Nucleophosmin 1 (NPM1) mutations in chronic myelomonocytic leukemia and their prognostic relevance (2017) (26)
- Clonal relationship between precursor B-cell acute lymphoblastic leukemia and histiocytic sarcoma: a case report and discussion in the context of similar cases. (2010) (26)
- Natural history of multiple myeloma with de novo del(17p) (2019) (26)
- Comparison of fluorescence in situ hybridization, p57 immunostaining, flow cytometry, and digital image analysis for diagnosing molar and nonmolar products of conception. (2010) (26)
- Molecular Epidemiology of Factor IX Germline Mutations in Mexican Hispanics: Pattern of Mutation and Potential Founder Effects (1995) (26)
- A past mutation at Isoleucine397 is now a common cause of moderate/mild haemophilia B (1990) (26)
- Inherited interstitial deletion of chromosomes 5p and 16q without apparent phenotypic effect: further confirmation (2000) (25)
- Validation of the WHO-defined 20% circulating blasts threshold for diagnosis of leukemic transformation in primary myelofibrosis (2018) (25)
- Epidemiology of adult acute myeloid leukemia: Impact of exposures on clinical phenotypes and outcomes after therapy. (2015) (25)
- Splanchnic vein thrombosis in patients with myeloproliferative neoplasms: The Mayo clinic experience with 84 consecutive cases (2018) (25)
- ASXL1 and CBL mutations are independently predictive of inferior survival in advanced systemic mastocytosis (2015) (24)
- False-negative rates for MYC fluorescence in situ hybridization probes in B-cell neoplasms (2018) (24)
- Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma (2019) (24)
- Evaluation of Revised International Staging System (R-ISS) for transplant-eligible multiple myeloma patients (2018) (24)
- Familial 22q11.2 deletions in DiGeorge/velocardiofacial syndrome are predominantly smaller than the commonly observed 3Mb (2004) (24)
- Isolated del(5q) in myeloid malignancies: Clinicopathologic and molecular features in 143 consecutive patients (2011) (24)
- Blast Phase Chronic Myelomonocytic Leukemia: Mayo-MDACC Collaborative study of 171 cases (2018) (23)
- Evaluation of a commercially available focused aCGH platform for the detection of constitutional chromosome anomalies (2007) (23)
- KMT2A (MLL) rearrangements observed in pediatric/young adult T‐lymphoblastic leukemia/lymphoma: A 10‐year review from a single cytogenetic laboratory (2018) (23)
- Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical Information (2018) (22)
- Utility of peripheral blood dual color, double fusion fluorescent in situ hybridization for BCR/ABL fusion to assess cytogenetic remission status in chronic myeloid leukemia (2006) (22)
- The pattern of spontaneous germ-line mutation: relative rates of mutation at or near CpG dinucleotides in the factor IX gene (1993) (22)
- Gender and survival in essential thrombocythemia: A two‐center study of 1,494 patients (2017) (22)
- Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study (2015) (22)
- Cytogenetic findings in WHO‐defined polycythaemia vera and their prognostic relevance (2018) (22)
- How precisely can data from transgenic mouse mutation-detection systems be extrapolated to humans?: lesions from the human factor IX gene. (1994) (22)
- Isolated trisomy 15: a clonal chromosome abnormality in bone marrow with doubtful hematologic significance. (2008) (21)
- Mutations and karyotype predict treatment response in myelodysplastic syndromes (2018) (21)
- IDH mutations and trisomy 8 in myelodysplastic syndromes and acute myeloid leukemia (2010) (21)
- Deletions with inversions: Report of a mutation and review of the literature (1993) (21)
- A mutation in the 3' untranslated region of the factor IX gene in four families with hemophilia B. (1993) (20)
- A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult disease (2018) (20)
- Cytogenetic Abnormalities in Essential Thrombocythemia: Prevalence and Prognostic Significance. (2006) (20)
- A comparison of clinical and molecular characteristics of patients with systemic mastocytosis with chronic myelomonocytic leukemia to CMML alone (2018) (20)
- Risk factors and a prognostic model for postsplenectomy survival in myelofibrosis (2017) (19)
- Screening for ASXL1 and SRSF2 mutations is imperative for treatment decision‐making in otherwise low or intermediate‐1 risk patients with myelofibrosis (2018) (19)
- Isochromosome 12p and polysomy 12 in primary central nervous system germ cell tumors: frequency and association with clinicopathologic features. (2010) (19)
- FISH identifies a KAT6A/CREBBP fusion caused by a cryptic insertional t(8;16) in a case of spontaneously remitting congenital acute myeloid leukemia with a normal karyotype (2017) (19)
- Analysis of HER2 gene amplification using an automated fluorescence in situ hybridization signal enumeration system. (2007) (19)
- Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations (2016) (18)
- Prognostic impact of ASXL1 mutations in patients with myelodysplastic syndromes and multilineage dysplasia with or without ring sideroblasts. (2018) (18)
- Recurrent nonsense mutations at arginine residues cause severe hemophilia B in unrelated hemophiliacs (1990) (18)
- Prognostic interaction between bone marrow morphology and SF3B1 and ASXL1 mutations in myelodysplastic syndromes with ring sideroblasts (2018) (18)
- Acute leukemias harboring KMT2A/MLLT10 fusion: a 10‐year experience from a single genomics laboratory (2019) (18)
- Independent Prognostic Significance of Monosomy 17 and Impact of Karyotype Complexity in Monosomal Karyotype/Complex Karyotype Acute Myeloid Leukemia: Results from Four ECOG-ACRIN Prospective Therapeutic Trials. (2017) (18)
- IDH mutations and trisomy 8 in myelodysplastic syndromes and acute myeloid leukemia. (2010) (18)
- Primary myelofibrosis is the most frequent myeloproliferative neoplasm associated with del(5q): clinicopathologic comparison of del(5q)-positive and -negative cases. (2008) (18)
- Development of a dual‐color, double fusion FISH assay to detect RPN1/EVI1 gene fusion associated with inv(3), t(3;3), and ins(3;3) in patients with myelodysplasia and acute myeloid leukemia (2010) (18)
- The B cell antigen receptor in atypical chronic lymphocytic leukemia with t(14;19)(q32;q13) demonstrates remarkable stereotypy (2011) (18)
- Primary Myelodysplastic Syndromes: The Mayo Clinic Experience With 1000 Patients. (2015) (17)
- Trisomy 13: prevalence and clinicopathologic correlates of another potentially lenalidomide-sensitive cytogenetic abnormality. (2009) (17)
- Bone Marrow Conventional Karyotyping and Fluorescence In Situ Hybridization: Defining an Effective Utilization Strategy for Evaluation of Myelodysplastic Syndromes. (2016) (17)
- TP53 mutations and polymorphisms in primary myelofibrosis (2011) (17)
- Automated Duet spot counting system and manual technologist scoring using dual-fusion fluorescence in situ hybridization (D-FISH) strategy: comparison and application to FISH minimal residual disease testing in patients with chronic myeloid leukemia. (2007) (17)
- Mutations and karyotype in myelodysplastic syndromes: TP53 clusters with monosomal karyotype, RUNX1 with trisomy 21, and SF3B1 with inv(3)(q21q26.2) and del(11q) (2017) (17)
- Cytogenetic abnormalities in systemic mastocytosis: WHO subcategory‐specific incidence and prognostic impact among 348 informative cases (2018) (17)
- Atypical generalized eruptive histiocytosis clonally related to chronic myelomonocytic leukemia with loss of Y chromosome (2013) (17)
- Germline mosaicism in a female who seemed to be a carrier by sequence analysis. (1995) (16)
- Clinicopathologic and Genetic Characterization of Follicular Lymphomas Presenting in the Ovary Reveals 2 Distinct Subgroups (2011) (16)
- A novel report of cig‐FISH and cytogenetics in POEMS syndrome (2008) (16)
- A postulated mechanism for deletions with inversions. (1993) (16)
- Conventional karyotyping and fluorescence in situ hybridization: an effective utilization strategy in diagnostic adult acute myeloid leukemia. (2015) (16)
- Clinical correlates, prognostic impact and survival outcomes in chronic myelomonocytic leukemia patients with the JAK2V617F mutation (2019) (16)
- High level MYC amplification in B-cell lymphomas: is it a marker of aggressive disease? (2020) (16)
- Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes (2013) (16)
- Implications of MYC Rearrangements in Newly Diagnosed Multiple Myeloma (2020) (16)
- A case of nonleukemic myeloid sarcoma with FIP1L1-PDGFRA rearrangement: an unusual presentation of a rare disease. (2013) (16)
- Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study (2015) (16)
- Somatic rearrangement of the TP63 gene preceding development of mycosis fungoides with aggressive clinical course (2014) (16)
- LMO2 Is a Specific Marker of T-Lymphoblastic Leukemia/Lymphoma. (2016) (16)
- Interphase FISH to detect PBX1/E2A fusion resulting from the der(19)t(1;19)(q23;p13.3) or t(1;19)(q23;p13.3) in paediatric patients with acute lymphoblastic leukaemia (2005) (15)
- Nearly identical near-haploid karyotype in a peritoneal mesothelioma and a retroperitoneal malignant peripheral nerve sheath tumor. (2010) (15)
- A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG‐ACRIN cancer research group (E1908) (2016) (15)
- A simple additive staging system for newly diagnosed multiple myeloma (2022) (15)
- Two novel factor IX promoter mutations: incremental progress towards 'saturation in vivo mutagenesis' of a human promoter region. (1995) (15)
- MPL-mutated essential thrombocythemia: a morphologic reappraisal (2018) (15)
- Erratum: Chronic myelomonocytic leukemia in younger patients: Molecular and cytogenetic predictors of survival and treatment outcome (Blood Cancer Journal (2015) 5 (e280) DOI: 10.1038/bcj.2015.9) (2015) (14)
- Primary central nervous system B cell lymphoma with features intermediate between diffuse large B cell lymphoma and Burkitt lymphoma. (2012) (14)
- Chromosome 5q deletion: specific diagnoses and cytogenetic details among 358 consecutive cases from a single institution. (2008) (14)
- Validation of a new three-color fluorescence in situ hybridization (FISH) method to detect CHIC2 deletion, FIP1L1/PDGFRA fusion and PDGFRA translocations. (2009) (14)
- Successful treatment of a child with T/myeloid acute bilineal leukemia associated with TLX3/BCL11B fusion and 9q deletion (2011) (14)
- T296→M, a common mutation causing mild hemophilia B in the Amish and others: founder effect, variability in factor IX activity assays, and rapid carrier detection (1991) (14)
- Comprehensive validation of array comparative genomic hybridization platforms: how much is enough? (2007) (13)
- The significance of genetic mutations and their prognostic impact on patients with incidental finding of isolated del(20q) in bone marrow without morphologic evidence of a myeloid neoplasm (2020) (13)
- Chromosomal rearrangements and copy number abnormalities of TP63 correlate with p63 protein expression in lung adenocarcinoma (2015) (13)
- Postimatinib therapy emergence of a new JAK2V617F clone and subsequent development of overt polycythemia vera in a patient with chronic myelogenous leukaemia (2010) (13)
- Concurrent activating KIT mutations in systemic mastocytosis (2016) (13)
- A prospective evaluation of vitamin B1 (thiamine) level in myeloproliferative neoplasms: clinical correlations and impact of JAK2 inhibitor therapy (2018) (13)
- Correlation of CYP2B6, CYP2C19, ABCC4 and SOD2 genotype with outcomes in allogeneic blood and marrow transplant patients. (2012) (12)
- Clinical, molecular, and prognostic comparisons between CCUS and lower-risk MDS: a study of 187 molecularly annotated patients. (2021) (12)
- Absence of somatic mosaicism in 17 families with hemophilia B: an analysis with a sensitivity 10- to 1000-fold greater than that of sequencing gels (1996) (12)
- Targeted Next-Generation Sequencing in Polycythemia Vera and Essential Thrombocythemia (2015) (12)
- Microdeletions in the factor IX gene: three recurrences associated with a quasipalindromic sequence. (1994) (12)
- Development of a D-FISH method to detect DEK/CAN fusion resulting from t(6;9)(p23;q34) in patients with acute myelogenous leukemia (2005) (12)
- Expression of the Chemokine Receptor Gene, CCR8, is Associated With DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma (2015) (12)
- Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myeloma. (2020) (12)
- Germline mutations in Peruvian patients with hemophilia B: Pattern of mutation in AmerIndians is similar to the putative endogenous germline pattern (1998) (12)
- Germline origins in the human F9 gene: frequent G:C→A:T mosaicism and increased mutations with advanced maternal age (1999) (12)
- Microgranular variant of acute promyelocytic leukemia with normal conventional cytogenetics, negative PML/RARA FISH and positive PML/RARA transcripts by RT-PCR. (2011) (12)
- The Utilization of Chromosomal Microarray Technologies for Hematologic Neoplasms: An ACLPS Critical Review (2018) (12)
- Missense mutations and the magnitude of functional deficit: the example of factor IX (1992) (12)
- Marked elevation of serum lactate dehydrogenase in primary myelofibrosis: clinical and prognostic correlates (2017) (12)
- Philadelphia chromosome mosaicism at diagnosis in chronic myeloid leukemia: Clinical correlates and effect on imatinib mesylate treatment outcome (2007) (11)
- Elucidating a false-negative MYC break-apart fluorescence in situ hybridization probe study by next-generation sequencing in a patient with high-grade B-cell lymphoma with IGH/MYC and IGH/BCL2 rearrangements (2019) (11)
- Development of a prognostically relevant cachexia index in primary myelofibrosis using serum albumin and cholesterol levels. (2018) (11)
- The germline JAK2 GGCC (46/1) haplotype and survival among 414 molecularly‐annotated patients with primary myelofibrosis (2018) (11)
- Impact of Alemtuzumab Therapy and Route of Administration in T-Prolymphocytic Leukemia: A Single-Center Experience. (2015) (11)
- Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma. (2020) (11)
- Molecular and Prognostic Correlates of Cytogenetic Abnormalities in Chronic Myelomonocytic Leukemia: A Mayo Clinic-French Consortium Study (2014) (11)
- Splenectomy in patients with chronic myelomonocytic leukemia: Indications, histopathological findings and clinical outcomes in a single institutional series of thirty‐nine patients (2018) (11)
- Characterization of a cryptic IGH/CCND1 rearrangement in a case of mantle cell lymphoma with negative CCND1 FISH studies. (2019) (11)
- Tipifarnib As Maintenance Therapy in Acute Myeloid Leukemia (AML) Improves Survival in a Subgroup of Patients with High Risk Disease. Results of the Phase III Intergroup Trial E2902 (2015) (11)
- Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi‐parametric flow cytometry method (2019) (10)
- Myeloid Sarcoma With CBFB-MYH11 Fusion (inv(16) or t(16;16)) Prevails in the Abdomen. (2019) (10)
- Are some apparently simple deletions actually two concerted deletions that result from interacting RY(i) hairpin loops? (1995) (10)
- Substratification of patients with newly diagnosed standard‐risk multiple myeloma (2019) (10)
- Nonhepatosplenic extramedullary manifestations of chronic myelomonocytic leukemia: clinical, molecular and prognostic correlates (2018) (10)
- Application of thrombolytic drugs on clotted blood and bone marrow specimens to generate usable cells for cytogenetic analyses. (2011) (10)
- Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms (2018) (10)
- Tetraploidy is associated with poor prognosis at diagnosis in multiple myeloma (2019) (10)
- Constitutional chromosome rearrangements that mimic the 2017 world health organization "acute myeloid leukemia with recurrent genetic abnormalities": A study of three cases and review of the literature. (2019) (9)
- Peripheral blood cytogenetic studies in hematological neoplasms: predictors of obtaining metaphases for analysis (2008) (9)
- Decreased Levels of Total or HDL Cholesterol in Primary Myelofibrosis Are Associated with Shortened Survival: DIPSS-Plus Independent Prognostic Value. (2012) (9)
- The Impact of Upfront Autologous Transplant on the Survival of Adult Patients with ALCL and PTCL-NOS According to Their ALK, DUSP22 and TP63 Gene Rearrangement Status - a Joined Nordic Lymphoma Group and Mayo Clinic Analysis (2017) (9)
- Hemophilia B in a male with a four-base insertion that arose in the germline of his mother. (1989) (9)
- Erratum: Molecular correlates of anemia in primary myelofibrosis: A significant and independent association with U2AF1 mutations (Blood Cancer Journal (2016) 6 (e415) DOI: 10.1038/bcj.2016.22) (2016) (9)
- Impact Of FISH Abnormalities On Response To Lenalidomide In Patients With Multiple Myeloma (2013) (9)
- 20+ Years and alive with primary myelofibrosis: Phenotypic signature of very long‐lived patients (2018) (9)
- Morphologically occult systemic mastocytosis in bone marrow: clinicopathologic features and an algorithmic approach to diagnosis. (2015) (9)
- Characterization of TCF3 rearrangements in pediatric B-lymphoblastic leukemia/lymphoma by mate-pair sequencing (MPseq) identifies complex genomic rearrangements and a novel TCF3/TEF gene fusion (2019) (9)
- Hyperhaploid plasma cell myeloma characterized by poor outcome and monosomy 17 with frequently co-occurring TP53 mutations (2019) (9)
- Development of five dual-color, double-fusion fluorescence in situ hybridization assays for the detection of common MLL translocation partners. (2010) (9)
- A 10 Day Schedule of Azacitidine Induces More Complete Cytogenetic Remissions Than the Standard Schedule In Myelodysplasia and Acute Myeloid Leukemia with Myelodysplasia-Related Changes: Results of the E1905 US Leukemia Intergroup Study (2010) (8)
- Cytogenetic analysis using multiple myeloma targets in POEMS syndrome (2007) (8)
- Section E 9 of the American College of Medical Genetics technical standards and guidelines : Fluorescence in situ hybridization (2011) (8)
- Landscape of RAS pathway mutations in patients with myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a study of 461 molecularly annotated patients (2020) (8)
- A leukemic presentation of a "triple-hit" lymphoma. (2014) (8)
- Momelotinib Therapy in Myelofibrosis: 6-Years Follow-up Data on Safety, Efficacy and the Impact of Mutations on Overall and Relapse-Free Survival (2016) (8)
- The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma (2021) (8)
- Early thrombotic events and preemptive systemic anticoagulation following splenectomy for myelofibrosis (2018) (7)
- A Test Utilization Approach to the Diagnostic Workup of Isolated Eosinophilia in Otherwise Morphologically Unremarkable Bone Marrow: A Single Institutional Experience (2018) (7)
- Cutaneous Extramedullary Plasmacytoma: Clinical, Prognostic, and Interphase Cytogenetic Analysis (2013) (7)
- Assessment of Isochromosome 12p & 12p Abnormalities in Germ Cell Tumors Using FISH, SNP-Arrays & NGS/ Mate-Pair Sequencing. (2021) (7)
- Momelotinib for myelofibrosis: 12‐year survival data and retrospective comparison to ruxolitinib (2022) (7)
- Identification of a Novel ZBTB20-JAK2 Fusion by Mate-Pair Sequencing in a Young Adult With B-Lymphoblastic Leukemia/Lymphoma. (2019) (7)
- Transient monosomy 7 in a chronic myelogenous leukemia patient during nilotinib therapy: a case report (2016) (7)
- Comparative study of therapy‐related and de novo adult b‐cell acute lymphoblastic leukaemia (2021) (7)
- Use of mate-pair sequencing to characterize a complex cryptic BCR/ABL1 rearrangement observed in a newly diagnosed case of chronic myeloid leukemia. (2019) (7)
- A case of hairy cell leukemia with CCND1-IGH@ translocation: indolent non-nodal mantle cell lymphoma revisited. (2011) (7)
- Abstract PD10-02: Round-Robin Review of HER2 Testing in the Context of Adjuvant Therapy for Breast Cancer (NCCTG N9831/BCIRG006/BCIRG005) (2010) (7)
- A Randomized Phase II Trial of Three Novel Regimens for Relapsed/ Refractory Acute Myeloid Leukemia (AML) Demonstrates Encouraging Results with a Flavopiridol-Based Regimen: Results of Eastern Cooperative Oncology Group (ECOG) Trial E1906 (2014) (7)
- Outcome of 1,229 Adult Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia (B-ALL) Patients (pts) From the International UKALLXII/E2993 Trial: No Difference In Results Between B Cell Immunophenotypic Subgroups (2010) (7)
- Deletion 5q is frequent in myelodysplastic syndrome (MDS) patients diagnosed with interstitial lung diseases (ILD): Mayo Clinic experience. (2016) (7)
- Two Distinct Subsets of dic(9;12)(p12;p11.2) among Children with B-Cell Precursor Acute Lymphoblastic Leukemia (ALL): PAX5-ETV6 and ETV6-RUNX1 Rearrangements: A Report from the Children’s Oncology Group. (2007) (6)
- Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post‐autologous stem cell transplantation lenalidomide maintenance therapy (2021) (6)
- The 2016 revised World Health Organization definition of ‘myelodysplastic syndrome with isolated del(5q)’; prognostic implications of single versus double cytogenetic abnormalities (2017) (6)
- Cytogenetic abnormalities in essential thrombocythemia: Clinical and molecular correlates and prognostic relevance in 809 informative cases (2022) (6)
- Peripheral blood cytogenetic studies in myelofibrosis: overall yield and comparison with bone marrow cytogenetic studies. (2008) (6)
- FGFR1 rearranged hematological neoplasms – molecularly defined and clinically heterogeneous (2018) (6)
- Detection of a cryptic NUP214/ABL1 gene fusion by mate-pair sequencing (MPseq) in a newly diagnosed case of pediatric T-lymphoblastic leukemia (2019) (6)
- Development of an NPM1/MLF1 D-FISH probe set for the detection of t(3;5)(q25;q35) identified in patients with acute myeloid leukemia. (2014) (6)
- Genetic Factors in Acute Myeloid Leukemia With Myelodysplasia-Related Changes. (2020) (6)
- CD36-positive B-lymphoblasts Predict Poor Outcome in Children With B-lymphoblastic Leukemia (2017) (6)
- Mutations at arginine residues in two Asian hemophilia B patients. (1990) (6)
- Fluorescence in‐situ hybridisation for TP63 rearrangements in T cell lymphomas: single‐site experience of 470 patients and implications for clinical testing (2020) (6)
- Characterization of a rarely reported STAT5B/RARA gene fusion in a young adult with newly diagnosed acute promyelocytic leukemia with resistance to ATRA therapy. (2019) (6)
- Is It Time for a New Gold Standard? FISH vs Cytogenetics in AML Diagnosis. (2016) (5)
- Clinical utility of fluorescence in situ hybridization‐based diagnosis of BCR‐ABL1 like (Philadelphia chromosome like) B‐acute lymphoblastic leukemia (2020) (5)
- Serum erythropoietin levels in essential thrombocythemia: phenotypic and prognostic correlates (2018) (5)
- Combined Tumors in Hematolymphoid Neoplasms: Case Series of Histiocytic and Langerhans Cell Sarcomas Arising From Low-Grade B-Cell Lymphoma (2019) (5)
- Genome-wide analysis reveals recurrent structural abnormalities of TP 63 and other p 53-related genes in peripheral T-cell lymphomas Running head : Genome-wide analysis of T-cell lymphomas (2012) (5)
- Mantle cell lymphoma with a novel t(11;12)(q13;p11.2): a proposed alternative mechanism of CCND1 up-regulation. (2017) (5)
- Myeloid malignancies with 5q and 7q deletions are associated with extreme genomic complexity, biallelic TP53 variants, and very poor prognosis (2021) (5)
- Discovery of 6 Novel Translocations Involving the Imatinib Responsive Genes PDGFRB and PDGFRB from Screening 29,047 Abnormal Bone Marrow Specimens. (2004) (5)
- Changing pattern for HER2 positivity due to updated ASCO/CAP guidelines for HER2 testing and its impact. (2014) (5)
- Myeloid Sarcoma: The Mayo Clinic Experience of Ninety Six Case Series (2016) (5)
- De novo isolated myeloid sarcoma: comparative analysis of survival in 19 consecutive cases (2021) (5)
- Failure of front-line autologous transplant in anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma (2011) (5)
- Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelide (2018) (5)
- Mutation-Enhanced International Prognostic Systems for Essential Thrombocythemia (MIPSS-ET) and Polycythemia Vera (MIPSS-PV) (2018) (5)
- Cryptic and atypical KMT2A‐USP2 and KMT2A‐USP8 rearrangements identified by mate pair sequencing in infant and childhood leukemia (2020) (5)
- Azacitidine With Or Without Entinostat For The Treatment Of Therapy-Related Myeloid Neoplasm: Further Results Of The E1905 North American Leukemia Intergroup Study (2013) (5)
- Molecular and phenotypic characterization of an early T-cell precursor acute lymphoblastic lymphoma harboring PICALM-MLLT10 fusion with aberrant expression of B-cell antigens. (2019) (5)
- Clinical utility of next generation sequencing to detect IGH/IL3 rearrangements [t(5;14)(q31.1;q32.1)] in B-lymphoblastic leukemia/lymphoma. (2021) (4)
- PRE: a novel element with the hallmarks of a retrotransposon derived from an unknown structural RNA. (1992) (4)
- High-Throughput Mutational Profiling In AML: Mutational Analysis of the ECOG E1900 Trial (2010) (4)
- CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes (2021) (4)
- Genomic stratification of myelodysplastic/myeloproliferative neoplasms, unclassifiable: Sorting through the unsorted (2021) (4)
- Erratum: Racial differences in primary cytogenetic abnormalities in multiple myeloma: A multi-center study (Blood Cancer Journal (2015) 5 (e279) DOI: 10.1038/bcj.2015.8) (2015) (4)
- Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients (2022) (4)
- Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations (2016) (4)
- 17p Deleted Multiple Myeloma: Clinical Outcomes and Predictive Factors For Acquisition Of 17p Deletion (2013) (4)
- A randomized trial of anthracycline dose intensification during induction of younger patients with acute myeloid leukemia: Results of Eastern Cooperative Oncology Group study E1900. (2009) (4)
- Monocytosis Is a Powerful and Independent Predictor of Shortened Overall and Leukemia-Free Survival in Primary Myelofibrosis (2016) (4)
- 20+ Years and Alive with Primary Myelofibrosis: Phenotypic Signature of Very Long-Lived Patients (2018) (4)
- Evidence for Cytogenetic and Fluorescence in Situ Hybridization (FISH) Risk Stratification of Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies. (2009) (4)
- R115777(tipifarnib) Improves Early Survival when Used As Maintenance Therapy for Elderly or Relapsed/Refractory Patients with Acute Myelogenous Leukemia in Remission (2012) (4)
- Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH‐based algorithm distinguishes prognostic groups and outcomes (2021) (4)
- Mayo Clinic experience with 1123 adults with acute myeloid leukemia (2021) (4)
- Myeloid neoplasm with eosinophilia associated with isolated extramedullary FIP1L1/PDGFRA rearrangement. (2018) (4)
- Treatment and Clinical Outcomes of High Grade B-Cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements (Double Hit/Triple Hit Lymphomas) (2016) (4)
- Composite Classic Hodgkin Lymphoma and Follicular Lymphoma (2022) (4)
- Assessment of isochromosome 12p and 12p abnormalities in germ cell tumors using fluorescence in situ hybridization, single-nucleotide polymorphism arrays, and next-generation sequencing/mate-pair sequencing (2021) (4)
- Effect of the Number of Prognostically Relevant Mutated Genes on Survival and Leukemia Progression in Primary Myelofibrosis (2013) (4)
- Prognostic Interactions Between SRSF2, ASXL1, and IDH Mutations in Primary Myelofibrosis and Determination of Added Value to Cytogenetic Risk Stratification and DIPSS-Plus (2012) (4)
- Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: a subset analysis from ECOG-ACRIN 1900 (2018) (4)
- A dynamic 3‐factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapy (2022) (3)
- Identification of a novel KMT2A/GIMAP8 gene fusion in a pediatric patient with acute undifferentiated leukemia (2020) (3)
- RNAseq identification of FISH‐cryptic BCL6::TP63 rearrangement in ALK‐negative anaplastic large‐cell lymphoma (2022) (3)
- Indolent Mantle Cell Lymphoma: A Distinct Subgroup Characterized by Leukemic Phase Disease without Lymphadenopathy. (2009) (3)
- “Cryptic” dinucleotide polymorphism in the 3′ region of the factor IX gene shows substantial variation among different populations (1994) (3)
- ASXL1 Mutations in Myelodysplastic Syndromes with 1% or More Ring Sideroblasts: Prevalence, Clinical Correlates and Prognostic Relevance (2015) (3)
- Proliferative Versus Dysplastic Chronic Myelomonocytic Leukemia: Molecular and Prognostic Correlates (2016) (3)
- Mutational analysis of candidate tumor-associated genes in acute megakaryoblastic leukemia (2009) (3)
- Revised Cytogenetic Risk Stratification in Primary Myelofibrosis: A Mayo Clinic Study of 903 Patients (2014) (3)
- Pentostatin, Cyclophosphamide, and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Phase 2 Trial of the ECOG-Acrin Cancer Research Group (E2903) (2019) (3)
- Phenotypic correlates and prognostic outcomes of TET2 mutations in myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: A comprehensive study of 504 adult patients (2020) (3)
- A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3‐ITD mutational status (2018) (3)
- Identification of t(1;19)(q12;p13) and ploidy changes in an ependymosarcoma: a cytogenetic evaluation (2012) (3)
- MYC break-apart FISH probe set reveals frequent unbalanced patterns of uncertain significance when evaluating aggressive B-cell lymphoma (2021) (3)
- MIPSS70: Mutation-Enhanced Prognostic System for Transplant Age Patients with Primary Myelofibrosis (2017) (3)
- Association of translocation t(11;14) with survival in patients with light chain (AL) amyloidosis (2008) (3)
- Integrative Genome-Wide DNA Methylation and Gene Expression Analysis Reveals Biological and Clinical Insights In Adult Acute Lymphoblastic Leukemia (2010) (3)
- Characterization of a cryptic PML-RARA fusion by mate-pair sequencing in a case of acute promyelocytic leukemia with a normal karyotype and negative RARA FISH studies (2019) (3)
- Concomitant myelodysplastic syndrome and chronic myeloid leukaemia: treatment outcomes with imatinib mesylate (2003) (3)
- Lymphocytopenia predicts shortened survival in myelodysplastic syndrome with ring sideroblasts (MDS‐RS) but not in MDS/MPN‐RS‐T (2021) (3)
- Acute myeloid leukemia after age 70 years: A retrospective comparison of survival following treatment with intensive versus HMA ± venetoclax chemotherapy (2021) (3)
- Cytogenetic clonal evolution in myeloproliferative neoplasms: contexts and prognostic impact among 648 patients with serial bone marrow biopsies (2019) (2)
- Monosomal Karyotype Predicts Adverse Prognosis In Patients With Chronic Myelomonocytic Leukemia (2013) (2)
- Cytogenetic Clonal Evolution in Myeloproliferative Neoplasms: Contexts and Prognostic Impact Among 650 Patients with Serial Bone Marrow Biopsies (2018) (2)
- Genetic predictors of response to specific drugs in primary myelofibrosis (2018) (2)
- Molecular Correlates of Anemia in Primary Myelofibrosis (2015) (2)
- Characterizing false-positive fluorescence in situ hybridization results by mate-pair sequencing in a patient with chronic myeloid leukemia and progression to myeloid blast crisis. (2020) (2)
- Cytogenetic Abnormalities in Systemic Mastocytosis: Who Subcategory-Specific Incidence and Prognostic Impact Among 348 Informative Cases (2018) (2)
- Sustained remission in a patient with myelodysplastic syndrome and a complex karyotype after erythropoiesis-stimulating therapy followed by colonic T-cell lymphoblastic lymphoma (2013) (2)
- Detection of cryptic CCND1 rearrangements in mantle cell lymphoma by next generation sequencing. (2020) (2)
- Marked elevation of serum lactate dehydrogenase in primary myelofibrosis: clinical and prognostic correlates (2016) (2)
- Anaplastic Angiocentric Glioma: A Report of Two Cases (2008) (2)
- A near‐haploid clone harboring a BCR/ABL1 gene fusion in an adult patient with newly diagnosed B‐lymphoblastic leukemia (2019) (2)
- Whole Genome Mate-pair Sequencing of Plasma Cell Neoplasm as a Novel Diagnostic Strategy: A Case of Unrecognized t(2;11) Structural Variation. (2019) (2)
- SF3B1-mutant myelodysplastic syndrome/myeloproliferative neoplasms: a unique molecular and prognostic entity (2022) (2)
- The rates of G:C[yields]T:A and G:C[yields]C:G transversions at CpG dinucleotides in the human factor IX gene (1994) (2)
- Low Level Amplification (Duplication) of 1q21 in Myeloma and Prognosis; the Role of CKS1B. (2005) (2)
- Conventional Cytogenetic Analysis of Hematologic Neoplasms: A 20-Year Review of Proficiency Test Results From the College of American Pathologists/American College of Medical Genetics and Genomics Cytogenetics Committee. (2020) (2)
- Lenalidomide therapy for primary myelodysplastic syndromes with isolated del(5q): Determinants of response and survival in a real‐world setting (2022) (2)
- Immunophenotypic and laboratory features of t(11;14)(q13;q32)-positive plasma cell neoplasms (2018) (2)
- Peripheral Blood Cytogenetic Studies in Hematological Neoplasms: Predictors of Obtaining Metaphases for Analysis. (2007) (2)
- ’Idiopathic’ Eosinophilia with an Occult T-Cell Clone: Prevalence, FIP1L1-PDGFRA Status, and Clinical Course. (2006) (2)
- Unique Clinical Epidemiologic Risk Factors Are Associated with Distinct Methylation Subgroups in Newly-Diagnosed Acute Myeloid Leukemia (AML) (2016) (2)
- Leukemic Transformation of Myeloproliferative Neoplasms in the Post-Ruxolitinib Era: Analysis of 103 Consecutive Cases Diagnosed 2011-2021 (2022) (2)
- Practice‐relevant demarcation of systemic mastocytosis associated with another hematologic neoplasm (2018) (2)
- Prognostic Impact of Morphology, MYC Gene Partner and BCL2/BCL6 Translocation Status in High Grade B-Cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements (2016) (2)
- Abstract C225: IL1RAP as functionally relevant target for stem-cell directed therapy in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). (2013) (2)
- Mutations and Thrombosis in Essential Thrombocythemia and Polycythemia Vera: Mayo-Careggi Alliance Study (2018) (2)
- 170 Azacitidine plus entinostat: Results from E1905, the first randomized trial adding a histone deacetylase inhibitor to a DNMT inhibitor (DNMTi) (2011) (2)
- Secondary acquisition of BCR-ABL1 fusion in de novo GATA2-MECOM positive acute myeloid leukemia with subsequent emergence of a rare KMT2A-ASXL2 fusion. (2019) (2)
- The Prognostic Significance of Acquired 1q22 Gain in Multiple Myeloma (2020) (2)
- Number and Type of TET2 Mutations in Chronic Myelomonocytic Leukemia: Clinical and Prognostic Correlates (2016) (2)
- Determinants of long-term outcome in type 1 calreticulin-mutated myelofibrosis (2018) (2)
- 3,023 Mayo Clinic Patients with Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups (2018) (2)
- Nucleic Acids Research (2017) (2)
- Driver Mutations and Prognosis in 502 Patients with Essential Thrombocythemia (2015) (2)
- Differences in the distribution of cytogenetic subtypes between multiple myeloma patients with and without a family history of monoclonal gammopathy and multiple myeloma (2013) (2)
- High Level MYC Amplification in Aggressive B-Cell Lymphomas: Is It a Marker of Aggressive Disease? (2018) (2)
- The Germline JAK2 GGCC (46/1) Haplotype and Survival Among 414 Molecularly-Annotated Patients with Primary Myelofibrosis (2018) (1)
- Identification of a Cryptic t(8;20;21)(q22;p13;q22) Resulting in RUNX1T1/RUNX1 Fusion in a Patient with Newly Diagnosed Acute Myeloid Leukemia. (2021) (1)
- Immunoglobulin Free Light Chain Levels Predict Survival in Primary Myelofibrosis and De Novo Myelodysplastic Syndromes (2011) (1)
- Myeloid Sarcoma With CBFB‐MYH11 Fusion (Inversion 16): A Clinicopathologic Analysis of 10 Cases: 209 (2018) (1)
- Prognostic significance of acquired 1q22 gain in multiple myeloma. (2021) (1)
- Impact of Novel Agents on Young Patients with t(11;14) Multiple Myeloma (2014) (1)
- Recurrent Chromosomal Abnormalities in Tissues Involved by Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. (2021) (1)
- ASXL1 and SETBP1 Mutations and Their Prognostic Contribution in Chronic Myelomonocytic Leukemia: An International Study of 466 Patients (2015) (1)
- ADDENDUM: Section E9 of the American College of Medical Genetics Technical Standards and Guidelines: Fluorescence in situ hybridization (2019) (1)
- Characterization of Atypical t(11;14) CCND1/IGH Translocations in Multiple Myeloma (2021) (1)
- U2AF1 Mutation Variants and Their Phenotypic and Prognostic Relevance in Primary Myelofibrosis (2016) (1)
- A 27-Gene NGS Panel in Primary Myelofibrosis Identifies ASXL1, CBL, RUNX1 and SRSF2 Mutations As Being Unfavorable and Absence of Any Non-Driver Mutation As Being Favorable to Survival (2015) (1)
- Revisiting the need for bone marrow examination in chronic myeloid leukemia (2018) (1)
- Characterization of unusual iAMP21 B‐lymphoblastic leukemia (iAMP21‐ALL) from the Mayo Clinic and Children's Oncology Group (2022) (1)
- single institution experience with 91 cases Leukemic transformation in myelofibrosis with myeloid metaplasia: a (2013) (1)
- Identification of EWSR1 rearrangements in patients with immature hematopoietic neoplasms: A case series and review of literature. (2022) (1)
- Adult Philadelphia-like B-cell acute lymphoblastic leukemia: Characteristics, outcomes, and role of allogeneic hematopoietic cell transplantation in comparison to Philadelphia-positive and Philadelphia-negative acute lymphoblastic leukemia. (2021) (1)
- Typical, atypical and cryptic t(15;17)(q24;q21) (PML::RARA) observed in acute promyelocytic leukemia: A retrospective review of 831 patients with concurrent chromosome and PML::RARA dual‐color dual‐fusion FISH studies (2022) (1)
- Siblings with ETV6/RUNX1-positive B-lymphoblastic leukemia: A single site experience and review of the literature. (2020) (1)
- Tipifarnib as maintenance therapy did not improve disease-free survival in patients with acute myelogenous leukemia at high risk of relapse: Results of the phase III randomized E2902 trial. (2021) (1)
- Apparent coexistence of ETV6::RUNX1 and KMT2A::MLLT3 fusions due to a nonproductive KMT2A rearrangement in B-ALL (2022) (1)
- Immunohistochemical Approach to Genetic Subtyping of Anaplastic Large Cell Lymphoma (2022) (1)
- Tipifarnib Is Well Tolerated as Maintenance Therapy In Acute Myeloid Leukemia (AML). Significant, but Non-Fatal, Hematologic Toxicity Not Ameliorated by Dose Reduction. Preliminary Results of the Phase III Intergroup Trial E2902 (2010) (1)
- Adverse karyotype subcategories in acute myeloid leukemia display significant differences in mutation composition and transplant-augmented survival (2022) (1)
- A rare case of atypical chronic myeloid leukemia associated with t(8;22)(p11.2;q11.2)/ BCR-FGFR1 rearrangement: A case report and literature review. (2021) (1)
- Novel Mutations in NOTCH and Altered Wnt/β-Catenin Pathway Indicate a Role of Embryonic Signals in the Pathogenesis of T-Cell Prolymphocytic Leukemia (2016) (1)
- Subnormal Lymphocyte Count Predicts Inferior Survival in Myelodysplastic Syndromes: A Single Center Experience in 889 Patients (2016) (1)
- Clonal Evolution As Determined By Sequential Bone Marrow Karyotype Analysis During JAK Inhibitor Therapy For Myelofibrosis: Impact On Treatment Response and Overall and Leukemia-Free Survival (2013) (1)
- Prognostic interaction between bone marrow morphology and SF3B1 and ASXL1 mutations in myelodysplastic syndromes with ring sideroblasts (2018) (1)
- Early Thrombotic Events Following Splenectomy for Myelofibrosis: Incidence, Risk Factors and Effect of Pre-Emptive Anticoagulant Therapy (2017) (1)
- Characterization of a cryptic KMT2A/AFF1 gene fusion by mate-pair sequencing (MPseq) in a young adult with newly diagnosed B-lymphoblastic leukemia (2019) (1)
- Efficacy of Mitoxantrone-Based Salvage Therapies in Relapsed or Refractory Acute Myeloid Leukemia in the Mayo Clinic Cancer Center: Analysis of Survival after CLAG-M Vs. MEC (2018) (1)
- Abnormal Karyotype and Prognosis in Polycythemia Vera: A Single Center Experience in 239 Informative Cases (2016) (1)
- 14q32 Abnormalities and 13q Deletions Are Common in Primary Systemic Amyloidosis Using Cytoplasmic Immunoglobulin Fluorescence In Situ Hybridization (cIg-FISH). (2007) (1)
- Anaplastic large-cell lymphoma (ALK-negative)-related heart failure and recurrence after heart transplantation. (2020) (1)
- Association of obesity with cytogenetic risk in adult acute myeloid leukemia (AML). (2014) (1)
- Biphenotypic Acute Leukemia versus Myeloid Antigen-Positive ALL: Clinical Relevance of WHO Criteria for Mixed Phenotype Acute Leukemia (2018) (1)
- A Novel Approach to Risk Stratification in Multiple Myeloma Using ISS Stage and FISH (2019) (1)
- Normal karyotype in myelofibrosis: is prognostic integrity affected by the number of metaphases analyzed? (2018) (1)
- When are apparently non-clonal abnormalities in bone marrow chromosome studies actually clonal? (2012) (1)
- ASXL1 and SETBP1 Mutations and Their Prognostic Contribution In Chronic Myelomonocytic Leukemia: An International Study Of 431 Patients (2013) (1)
- CDKN2A-deletion to predict relapse in adult B-cell acute lymphoblastic leukemia (B-ALL). (2012) (1)
- randomized prospective trial (UKALL XII/ECOG 2993) immunophenotype, cytogenetics, and outcome from the large T-cell acute lymphoblastic leukemia in adults: clinical features, (2013) (1)
- The impact of sex on disease phenotype and prognostic thresholds of anemia in myelodysplastic syndromes (2018) (1)
- Survival and Prognosis in World Health Organization Defined Chronic Myelomonocytic Leukemia- A Mayo Clinic Series of 227 Patients (2012) (1)
- Driver Mutations and Prognosis in 1118 Patients with Primary Myelofibrosis (2015) (1)
- Feasibility of Hematopoietic Stem Cell Transplantation for T-Prolymphocytic Leukemia. Experience of a Large Referral Center (2015) (0)
- Therapy-Related Myelodysplastic Syndromes with Isolated Del(5q): Comparative Analysis of Phenotype and Long-Term Survival (2022) (0)
- Test Samples and Laboratory Protocols (2006) (0)
- The 2016 Revised World Health Organization Classification of 'Myelodysplastic Syndrome with Isolated Del(5q)'; Prognostic Implications of Single Versus Double Cytogenetic Abnormalities (2016) (0)
- Normal Karyotype Primary Myelofibrosis (NK-PMF): Clinical and Molecular Prognostication In 690 Patients (2013) (0)
- Vascular Events and Risk Factors for Thrombosis in Refractory Anemia with Ring Sideroblasts and Thrombocytosis (RARS-T) (2015) (0)
- Deletion 5q in WHO-Defined Myeloproliferative Neoplasms: A Clinicopathological Description. (2007) (0)
- Anthracycline Choices for Induction Chemotherapy Among 797 Consecutive Adult Patients with Acute Myeloid Leukemia: Daunorubicin-60 Vs Idarubicin-12 Vs Daunorubicin-90 (2021) (0)
- Validation of the WHO-defined 20% circulating blasts threshold for diagnosis of leukemic transformation in primary myelofibrosis (2018) (0)
- Transdifferentiation of high-grade B-cell lymphoma with MYC and BCL2 rearrangements into histiocytic sarcoma after CAR T-cell therapy: a case report (2022) (0)
- Cytogenetics in Essential Thrombocythemia: Phenotype and Molecular Correlates and Prognostic Relevance in 818 Informative Cases (2021) (0)
- 24. Clinical utility of mate pair sequencing as a reflex test in B-lymphoblastic leukemia/lymphoma (2021) (0)
- Secondary Precursor T-Cell Lymphoblastic Lymphoma Following Precursor B-cell Acute Lymphoblastic Leukemia: A Case Report and Review of the Literature (2014) (0)
- Presence of interstitial lung diseases (ILD) in patients diagnosed with myelodysplastic syndromes (MDS): Mayo Clinic experience. (2016) (0)
- Functional evaluation of isocitrate dehydrogenase 1 and 2 variants of unclear significance in chronic myeloid neoplasms. (2019) (0)
- Autologous Hematopoietic Cell Transplantation as Consolidation for Younger Patients with Acute Myeloid Leukemia in First Complete Remission: Follow-up of E1900. (2009) (0)
- Peripheral Blood Cytogenetic Studies in Myelofibrosis: Overall Yield and Comparison with Bone Marrow Cytogenetic Studies (2007) (0)
- E 9 of the American College of Medical Genetics technical standards and guidelines : Fluorescence in situ hybridization (2011) (0)
- metaphase and/or interphase cells at diagnosis of myeloma Relationship of patient survival and chromosome anomalies detected in (2013) (0)
- Whole-Genome Mate-Pair Sequencing (MPseq) Improves Genomic Characterization of Patients with Hematologic Malignancies (2016) (0)
- Compendium of Karyotypic Abnormalities and Their Clinical Implications in Hyperdiploid Multiple Myeloma (H-MM). (2005) (0)
- Clinical Correlates, Prognostic Impact and Survival Outcomes in Chronic Myelomonocytic Leukemia Patients with Myeloproliferative Neoplasm Associated-Driver Mutations (2018) (0)
- Young Adults Presenting with Extramedullary Acute Myeloid Leukemia Have A Unique Sensitivity to High Doses of Anthracyclines: Subset Analysis of ECOG 1900, (2011) (0)
- Gene Expression Profiling Identifies Distinct Signatures for Dysplastic and Proliferative Chronic Myelomonocytic Leukemia (2016) (0)
- Chronic phase CML with sole P190 (e1a2) BCR::ABL1: long-term outcome among ten consecutive cases (2022) (0)
- Dual Primary IGH Translocations in Multiple Myeloma: A Novel Finding. (2021) (0)
- Mechanisms of the Formation of Multinuclear Malignant Plasma Cells in the Novel AL/MM Human Cell Lines, ALMC-1 and ALMC-2: Implications for Tumor Cell Growth Control. (2008) (0)
- and other p53-related genes in peripheral T-cell lymphomas TP63 Genome-wide analysis reveals recurrent structural abnormalities of (2012) (0)
- Group 3999 leukemia : a randomized , placebo-controlled trial of the Eastern outcome of older patients with newly diagnosed acute myeloid Zosuquidar , a novel modulator of P-glycoprotein (2010) (0)
- Prognostic Relevance of Monocytopenia and Lymphocyte-to-Monocyte Ratio in Primary Myelodysplastic Syndromes (2016) (0)
- Cover Image (2018) (0)
- Evaluation of the BioView DuetTM automated FISH counting system for minimal residual disease testing in patients with chronic myelogenous leukemia (2003) (0)
- Prognostic and therapeutic impact of cytogenetic abnormalities in patients with myelodysplastic/myeloproliferative neoplasms, unclassifiable. (2017) (0)
- 12. Mate pair sequencing: Unveiling underappreciated complexity and providing clarity to the previously unanswered questions of cytogenetics (2018) (0)
- Clinical Value of Next Generation Sequencing in the Detection of Recurring Structural Rearrangements and Copy Number Abnormalities in Acute Myeloid Leukemia (2020) (0)
- Natural History, Genetic Aberrations and Survival Distinguish Primary Plasma Cell Leukemia from Multiple Myeloma with Leukemic Transformation. (2006) (0)
- U2AF1 mutations In Primary Myelofibrosis Cluster With Normal Karyotype and JAK2V617F and Are Strongly Associated With Anemia and Thrombocytopenia (2013) (0)
- Differentiating between Hyperdiploidy and Pseudo-Hyperdiploidy in B-Lymphoblastic Leukemia Utilizing Low-Coverage Mate-Pair Sequencing (2019) (0)
- 1,123 Consecutive Adults with Non-APL Acute Myeloid Leukemia: The Mayo Clinic Experience (2018) (0)
- Utilizing next-generation sequencing to characterize a case of acute myeloid leukemia with t(4;12)(q12;p13) in the absence of ETV6/CHIC2 and ETV6/PDGFRA gene fusions. (2021) (0)
- Monosomal Karyotype (MK) In Older Patients with Acute Myeloid Leukemia (AML) on Eastern Cooperative Oncology Group (ECOG) Therapeutic Trials: Poor Prognostic Impact of MK, but Not of Monosomy 7 (2010) (0)
- Clonal Markers In Relapsed Acute Promyelocytic Leukemia (APL): Clinicopathological Associations and Relation to All-Trans Retinoic Acid (ATRA) Treatment on Intergroup Phase III Trial C9710. (2010) (0)
- Spliceosome Mutations Involving SRSF2, SF3B1 and U2AF35 in World Health Organization Defined Chronic Myelomonocytic Leukemia; Prevalence, Clinical Correlates and Prognosis (2012) (0)
- 14. Clinical mate-pair sequencing reveals complex genomic rearrangements in B-lymphoblastic leukemia/lymphoma (B-ALL) (2018) (0)
- Predictors of Spleen and Anemia Response to Specific Drugs in Primary Myelofibrosis (2018) (0)
- Recurrent Chromosomal Abnormalities in Tumoral Lesions of Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia: A Large-Scale Fluorescent in-Situ Hybridization Study on Tissue Biopsy Sections (2019) (0)
- Mate pair sequencing outperforms fluorescence in situ hybridization and improves diagnostic yield in the genomic characterization of multiple myeloma (2019) (0)
- essential thrombocythemia, polycythemia vera, and myelofibrosis Long-term survival and blast transformation in molecularly annotated (2014) (0)
- 13. NGS-based detection of translocations in plasma cell myeloma (2019) (0)
- Free light chain assay and cytogenetic abnormalities for identification of high-risk smoldering myeloma. (2014) (0)
- Acute Myeloid Leukemia in the Context of Previous History of Cancer with or without Exposure to Chemotherapy or Radiotherapy (2021) (0)
- 35. Frequencies of Turner syndrome abnormalities as detected by high resolution chromosomal microarray in products of conception and postnatal blood samples (2021) (0)
- 30. Characterization of atypical iAMP21 observed in B-Lymphoblastic Leukemia (B-ALL): a 2.5-year retrospective study from the Mayo Clinic (2021) (0)
- Normal karyotype in myelofibrosis: is prognostic integrity affected by the number of metaphases analyzed? (2018) (0)
- Blast Transformation in Chronic Myelomonocytic Leukemia: Risk Factors and Outcome (2014) (0)
- TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo‐Moffitt study of 156 informative cases (2023) (0)
- Characterization of Genetic Findings Underlying Aggressive B-Cell Lymphomas with Atypical Results on MYC Break-Apart Fluorescence in Situ Hybridization (FISH) Analysis (2022) (0)
- Survival Trends in Essential Thrombocythemia in the Face of Changing Treatment Practices (2015) (0)
- Momelotinib Therapy for Myelofibrosis: Impact on Long-Term Survival and Genotype Correlations (2015) (0)
- Evaluation of Revised International Staging System for Transplant-Eligible Multiple Myeloma Patients (2016) (0)
- Detection of t(5;14)(q31.1;q32.1) [IGH/IL3] in B-lymphoblastic leukemia by next generation sequencing (2021) (0)
- Copy Number Abnormalities Of The Interferon Regulatory Factor-4 ( IRF4 ) Gene Are Associated With IRF4/MUM1 Expression In Peripheral T-Cell Lymphomas (2013) (0)
- Impact of Acquired Del(17p) in Patients with Multiple Myeloma (2018) (0)
- 13. Clinical utility of mate pair sequencing to detect diagnostic and prognostic chromosomal rearrangements and copy number changes in patients with acute myeloid leukemia (2018) (0)
- Revised DIPSS-Plus: A Composite Clinical, Cytogenetic and Molecular Prognostic System for Primary Myelofibrosis (2017) (0)
- Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma (2019) (0)
- A simple additive staging system for newly diagnosed multiple myeloma (2022) (0)
- Evaluation of IPSS-Revised (IPSS-R) Cytogenetic Risk Stratification and Prognostic Impact of Monosomal Karyotype in 1,014 Patients with Myelodysplastic Syndromes (MDS) (2012) (0)
- Association of prior epidemiologic exposures with cytogenetic risk in adult acute myeloid leukemia (AML). (2013) (0)
- Daunorubicin-60 versus daunorubicin-90 versus idarubicin-12 for induction chemotherapy in acute myeloid leukemia: a retrospective analysis of the Mayo Clinic experience (2022) (0)
- Leukemic transformation among 1306 patients with primary myelofibrosis: risk factors and development of a predictive model (2019) (0)
- Development of a Clinical Grade Interpretive Tool for Neoplastic Genomic Microarray Testing (2016) (0)
- MPL-mutated essential thrombocythemia: a morphologic reappraisal (2018) (0)
- Increased complexity of t(11;14) rearrangements in plasma cell neoplasms compared with mantle cell lymphoma (2021) (0)
- Next-Generation Sequencing in Myelodysplastic Syndromes: Prognostic Interaction Between Adverse Mutations and IPSS-R (2016) (0)
- Additional Cytogenetic Abnormalities and/or Philadelphia Chromosome Metaphase Mosaicism Might Adversely Influence Survival and Imatinib Response in Chronic Myeloid Leukemia. (2006) (0)
- Bone Marrow Histologic and Cytogenetic Changes during Leukemic Transformation of Myelofibrosis with Myeloid Metaplasia. (2004) (0)
- IPSS-Molecular but Not Individual Mutations Predicts Outcomes of Patients with Myelodysplastic Syndrome (MDS) after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT): A Mayo Clinic Cohort (2022) (0)
- Hyperhaploid plasma cell myeloma characterized by poor outcome and monosomy 17 with frequently co-occurring TP53 mutations (2019) (0)
- The significance of genetic mutations and their prognostic impact on patients with incidental finding of isolated del(20q) in bone marrow without morphologic evidence of a myeloid neoplasm (2020) (0)
- A prospective evaluation of vitamin B1 (thiamine) level in myeloproliferative neoplasms: clinical correlations and impact of JAK2 inhibitor therapy (2019) (0)
- Low Incidence of FIP1L1-PDGFRA in Eosinophilic Patients and Long-Term Experience with Imatinib Therapy. (2005) (0)
- Development of a Custom, Sensitive and Specific PCR Strategy for the Detection of ERG Deletions in Pediatric B- Lymphoblastic Leukemia/Lymphoma (B-ALL) (2017) (0)
- Prognostic Implications of Multiple Cytogenetic High-Risk Abnormalities in Patients with Newly Diagnosed Multiple Myeloma (2016) (0)
- A 10-Year Review of KMT2A Gene Fusion Partners Observed in Pediatric T-Lymphoblastic Leukemia/Lymphoma: The Mayo Clinic Experience (2018) (0)
- Risk Factors for Leukemic Transformation Among 1,306 Patients with Primary Myelofibrosis: Mutations Predict Early Events (2018) (0)
- Identification of Serum Lactate Dehydrogenase (LDH) As an Independent Prognostic Biomarker in Polycythemia Vera (2016) (0)
- Determinants of Long-Term Outcome in Type 1/like Calreticulin-Mutated Myelofibrosis (2018) (0)
- The Impact of Obesity on the Presentation & Outcome of Adult Acute Myeloid Leukemia (AML) - ECOG Studies E1900 & E3999 (2011) (0)
- Cytogenetic Studies at Diagnosis in Polycythemia Vera: Clinical and JAK2V617F Allele Burden Correlates. (2007) (0)
- Momelotinib therapy for myelofibrosis: a 7-year follow-up (2018) (0)
- A TRIP11: FLT3 gene fusion in a patient with myeloid/lymphoid neoplasm with eosinophilia and tyrosine kinase gene fusions: a case report and review of the literature. (2023) (0)
- Blast phase myeloproliferative neoplasm with prior exposure to ruxolitinib: comparative analysis of mutations and survival. (2023) (0)
- Abstract 3538: Genetic biomarkers for risk stratification of patients with peripheral T-cell lymphoma. (2013) (0)
- Mutations and karyotype in myelodysplastic syndromes: TP53 clusters with monosomal karyotype, RUNX1 with trisomy 21, and SF3B1 with inv(3)(q21q26.2) and del(11q) (2017) (0)
- False-Negative Centromere 15 Probe Results in Association with African Ancestry in Plasma Cell Dyscrasias (2021) (0)
- Frequency of Acquired Genetic Mutations and Their Prognostic Impact on Patients with Incidental Finding of Isolated 20q- in Bone Marrow without Morphologic Evidence of a Myeloid Neoplasm (2018) (0)
- Somatic mosaicism in families with hemophilia B: 11% of germline mutations originate within a few cell divisions post-fertilization (1994) (0)
- Rearrangements of IER3 Represent a Novel and Recurrent Molecular Abnormality in Myelodysplastic Syndromes (MDS) (2008) (0)
- Clinical Outcome of Therapy-Related Acute Myeloid Leukemia Is Strongly Related to Cytogenetic Analysis (2015) (0)
- Natural history of patients with myelodysplastic syndromes (MDS) with interstitial deletions of chromosome 5q detected on G-banded karyotyping (2007) (0)
- Genetic Determinants of Response and Survival in Momelotinib Treated Myelofibrosis Patients (2014) (0)
- Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 rearrangements in Anaplastic Large Cell Lymphoma (2020) (0)
- Abstract 272: Evidence of decreased prevalence of the t(11;14) translocation in black patients with multiple myeloma: A multi-center study (2014) (0)
- Clinical and Molecular Models of Prognostication in Mastocytosis: Analysis Based on 580 Consecutive Cases (2018) (0)
- Metaphase Cytogenetics for Risk Stratification in Newly Diagnosed Multiple Myeloma (2019) (0)
- The Effect of Number of Metaphases Studied and Abnormal Metaphase Percentage On Cytogenetic Risk Stratification in Primary Myelofibrosis (2012) (0)
- Isolated Trisomy 8 in the Myelodysplastic Syndromes. (2009) (0)
- 67. NUP98 rearrangements in hematologic malignancies: A 4-year review from the genomics laboratory (2020) (0)
- Cytogenetic abnormalities in MM: Association with disease characteristics and treatment response. (2020) (0)
- Evolutionary pattern of mutation in the factor IX genes of great apes: How does it compare to the pattern of recent germline mutation in patients with hemophilia B? (1994) (0)
- Calculator‐free point‐of‐care prognostication in myelodysplastic syndromes (2019) (0)
- Myeloproliferative Neoplasms in Young Patients: The Mayo Clinic Experience with 361 Cases Age 40 Years or Younger (2018) (0)
- DNTM3A Mutations and Prognosis in Chronic Myelomonocytic Leukemia (2016) (0)
- Heterogeneity of MYC Abnormalities in Multiple Myeloma (2020) (0)
- Use of Mate-Pair Sequencing (MPseq) to Elucidate a Complex BCR-ABL1 Rearrangement Observed in a Newly Diagnosed Case of Chronic Myeloid Leukemia (2018) (0)
- Association of Clinical Epidemiologic Exposures and Overall Survival with Genome-Wide DNA Methylation Profiles in Acute Myeloid Leukemia: Analysis of the Mayo Clinic AML Epidemiology Cohort (2018) (0)
- Treatment-influenced associations of PML-RAR (cid:1) mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia (2012) (0)
- Deletion 5q in AML: A Clinicopathological Description of 79 Cases from a Single Institution (2008) (0)
- Cytogenetic Abnormalities Predict Clinical Outcome In Patients Diagnosed With Relapsed Acute Myeloid Leukemia (rAML): Single Center Experience (2013) (0)
- 152 BONE MARROW CONVENTIONAL KARYOTYPING AND FLUORESCENCE IN SITU HYBRIDIZATION (FISH): DEFINING AN EFFECTIVE UTILIZATION STRATEGY FOR THE EVALUATION OF MYELODYSPLASTIC SYNDROME (MDS) (2015) (0)
- Cytogenetics of Infant/Congenital Leukemia: Mayo Clinic Experience From 2005–2015 (2016) (0)
- An Evidence‐Based Approach to the Diagnostic Workup of Eosinophilia in Morphologically Normal Bone Marrow: 195 (2018) (0)
- Utility of Genome-Wide Characterization of B-Cell Acute Lymphoblastic Leukemia Using SNP-Based Microarray (2016) (0)
- Utilization of Mate-Pair Sequencing to Characterize Complex and Novel TCF3 Translocations (2016) (0)
- Lymphoma-like double-hit genetic abnormalities (MYC/IGH and IGH/BCL2) in a case of non-secretory multiple myeloma (2020) (0)
- Splanchnic Vein Thrombosis in Overt Myeloproliferative Neoplasms: The Mayo Clinic Experience with 107 Unselected Consecutive Cases (2017) (0)
- Natural history of multiple myeloma with de novo del(17p) (2019) (0)
- Phenotypic and Prognostic Relevance of the Who Diagnostic Distinction between Polycythemia Vera and JAK2 -Mutated Essential Thrombocythemia: Combined Analysis of 785 Informative Cases (2017) (0)
- Detection of a Cryptic EP300/ZNF384 Gene Fusion by Chromosomal Microarray and Next-Generation Sequencing Studies in a Pediatric Patient with B-Lymphoblastic Leukemia. (2020) (0)
- Abstract 1208: Discovery of a previously undescribed cutaneous T-cell neoplasm with chromosomal rearrangements of 6p25.3. (2013) (0)
- 8. Mate pair sequencing characterization of 5q/7q co-deleted acute myeloid leukemia: a prospective study to discover novel co-abnormalities in complex karyotypes (2019) (0)
- Chronic Myelomonocytic Leukemia in Young Patients: Molecular and Cytogenetic Predictors of Survival and Treatment Outcome (2014) (0)
- Characterization of a t(1;2)(p36;p21) involving the PRDM16 gene region by mate-pair sequencing (MPseq) in a patient with newly diagnosed acute myeloid leukemia with myelodysplasia-related changes (2019) (0)
- Vitreoretinal Involvement by Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract Diagnosed by Fluorescence In Situ Hybridization (2022) (0)
- The Anatomy of Recurrent Thrombosis and Its Risk Factors in Myeloproliferative Neoplasms (2017) (0)
- 8p11.2 Translocations: Prevalence, FISH Analysis for FGFR1 and MYST3, and Clinicopathologic Correlates in a Consecutive Cohort of 13 Cases From a Single Institution. (2009) (0)
- Parallel Transcriptional Analysis of Multiple Stem and Progenitor Populations Identifies Novel Commonly Dysregulated and Functionally Relevant Targets in AML (2012) (0)
- Development of highly sensitive FISH assays for diagnosis and minimal residual disease detection of inv /rpn1-evil fusion and t /dek-can fusion in patients with acute myelogenous leukemia (2003) (0)
- Cryptic t(6;11) KMT2A rearrangement in a pediatric acute myeloid leukemia patient detected by next‐generation sequencing and dual‐fusion FISH analysis (2021) (0)
- Abstract 655: Hyperdiploidy in plasma cell disorders using multi-parametric flow cytometry (MFC) vs. FISH (2018) (0)
- Predicting Poor Overall Survival in Patients with Newly Diagnosed Multiple Myeloma and Standard-Risk Cytogenetics Treated with Novel Agents (2016) (0)
- light chain-secreting human cell lines, ALMC-1 and ALMC-2 Biologic and genetic characterization of the novel amyloidogenic lambda (2013) (0)
- Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) (2023) (0)
- Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG‐ACRIN analysis (2023) (0)
- Association of epidemiologic exposures with complete remission after therapy in acute myeloid leukemia (AML). (2014) (0)
- Serum erythropoietin levels in essential thrombocythemia: phenotypic and prognostic correlates (2018) (0)
- Phenotypic and Prognostic Correlates of Spliceosome Mutations (SRSF2, SF3B1, U2AF35) in Chronic Myelomonocytic Leukemia with ≥ 1% Ring Sideroblasts. (2012) (0)
- Clonally-Related Composite Classic Hodgkin Lymphoma and Follicular Lymphoma (2021) (0)
- Genetic predictors of response to specific drugs in primary myelofibrosis (2018) (0)
- ADDENDUM: Section E9 of the American College of Medical Genetics Technical Standards and Guidelines: Fluorescence in situ hybridization (2019) (0)
- Fluorescence in-Situ Hybridization (FISH) Analysis in Untreated AL Amyloidosis Has an Independent Prognostic Impact By Abnormality Type and Treatment Category (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Rhett P. Ketterling?
Rhett P. Ketterling is affiliated with the following schools:
